Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Silicone Breast Implant Return To U.S. Market Heralded By Modular PMA

This article was originally published in The Gray Sheet

Executive Summary

Inamed likely will be first to the U.S. market with a silicone gel-filled breast implant in the wake of FDA's 1992 call for PMAs for the pre-amendments devices
Advertisement

Related Content

FDA, Congress Examine Saline Implant Data; Silicone PMA Expected In 2002
FDA, Congress Examine Saline Implant Data; Silicone PMA Expected In 2002
Inamed Outlines Facial Aesthetic Pipeline; Focuses On Lap-Band Sales Growth
Inamed Outlines Facial Aesthetic Pipeline; Focuses On Lap-Band Sales Growth
Kensey Nash Stock Price Up In January On St. Jude Angio-Seal Sales
Kensey Nash Stock Price Up In January On St. Jude Angio-Seal Sales
CTD Clinical Follow-Up Still Needed For Breast Implants, FDA Maintains
Mentor's $32 Mil. Porges Purchase Boosts European Urology Presence
Saline-Filled Breast Implant Labels Note 13-40% Re-operation Rate At 3 Years
Saline-Filled Breast Implant Labels Note 13-40% Re-operation Rate At 3 Years
Advertisement
UsernamePublicRestriction

Register

MT016062

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel